Cargando…
Cannabidiol (CBD) Alters the Functionality of Neutrophils (PMN). Implications in the Refractory Epilepsy Treatment
Cannabidiol (CBD), a lipophilic cannabinoid compound without psychoactive effects, has emerged as adjuvant of anti-epileptic drugs (AEDs) in the treatment of refractory epilepsy (RE), decreasing the severity and/or frequency of seizures. CBD is considered a multitarget drug that could act throughout...
Autores principales: | Gómez, Claudia Taborda, Lairion, Fabiana, Repetto, Marisa, Ettcheto, Miren, Merelli, Amalia, Lazarowski, Alberto, Auzmendi, Jerónimo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8001508/ https://www.ncbi.nlm.nih.gov/pubmed/33807975 http://dx.doi.org/10.3390/ph14030220 |
Ejemplares similares
-
Cannabidiol (CBD) Inhibited Rhodamine-123 Efflux in Cultured Vascular Endothelial Cells and Astrocytes Under Hypoxic Conditions
por: Auzmendi, Jerónimo, et al.
Publicado: (2020) -
Is cannabidiol a drug acting on unconventional targets to control drug‐resistant epilepsy?
por: Rocha, Luisa, et al.
Publicado: (2020) -
Myocardial Iron Overload in an Experimental Model of Sudden Unexpected Death in Epilepsy
por: Akyuz, Enes, et al.
Publicado: (2021) -
Convulsive Stress Mimics Brain Hypoxia and Promotes the P-Glycoprotein (P-gp) and Erythropoietin Receptor Overexpression. Recombinant Human Erythropoietin Effect on P-gp Activity
por: Merelli, Amalia, et al.
Publicado: (2019) -
Uridine Diphosphate Glucose (UDP-G) Activates Oxidative Stress and Respiratory Burst in Isolated Neutrophils
por: Lairion, Fabiana, et al.
Publicado: (2023)